4//SEC Filing
Furey John 4
Accession 0001609351-18-000038
CIK 0001609351other
Filed
Apr 23, 8:00 PM ET
Accepted
Apr 24, 4:30 PM ET
Size
8.2 KB
Accession
0001609351-18-000038
Insider Transaction Report
Form 4
Furey John
Chief Operating Officer
Transactions
- Exercise/Conversion
Employee Stock Option (right to buy)
2018-04-20−6,723→ 120,000 totalExercise: $49.74Exp: 2026-11-30→ Common Stock (6,723 underlying) - Exercise/Conversion
Common Stock
2018-04-20$49.74/sh+6,723$334,402→ 6,723 total - Sale
Common Stock
2018-04-20$82.50/sh−6,723$554,648→ 0 total
Footnotes (2)
- [F1]The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2017.
- [F2]25% vests December 1, 2017 and the remainder vests in equal quarterly installments over the following three years following December 1, 2017.
Documents
Issuer
Spark Therapeutics, Inc.
CIK 0001609351
Entity typeother
Related Parties
1- filerCIK 0001691218
Filing Metadata
- Form type
- 4
- Filed
- Apr 23, 8:00 PM ET
- Accepted
- Apr 24, 4:30 PM ET
- Size
- 8.2 KB